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Abstract: Dietary protein and fiber independently influence insulin-mediated glucose control.
However, potential additive effects are not well-known. Men and women (n = 20; age: 26 ± 5 years;
body mass index: 26.1 ± 0.2 kg/m2; mean ± standard deviation) consumed normal protein and
fiber (NPNF; NP = 12.5 g, NF = 2 g), normal protein and high fiber (NPHF; NP = 12.5 g, HF
= 8 g), high protein and normal fiber (HPNF; HP = 25 g, NF = 2 g), or high protein and fiber
(HPHF; HP = 25 g, HF = 8 g) breakfast treatments during four 2-week interventions in a randomized
crossover fashion. On the last day of each intervention, meal tolerance tests were completed to assess
postprandial (every 60 min for 240 min) serum glucose and insulin concentrations. Continuous
glucose monitoring was used to measure 24-h interstitial glucose during five days of the second
week of each intervention. Repeated-measures ANOVA was applied for data analyses. The HPHF
treatment did not affect postprandial glucose and insulin responses or 24-h glucose total area under
the curve (AUC). Higher fiber intake reduced 240-min insulin AUC. Doubling the amount of protein
from 12.5 g to 25 g/meal and quadrupling fiber from 2 to 8 g/meal at breakfast was not an effective
strategy for modulating insulin-mediated glucose responses in these young, overweight adults.
Keywords: dietary protein; dietary fiber; breakfast; overweight; continuous glucose monitoring;
meal tolerance test
1. Introduction
Type 2 diabetes (T2D) is a chronic metabolic disease that is impacted by insulin resistance, glucose
intolerance, and dyslipidemia [1–3]. Dietary factors that influence blood glucose control may modify
these metabolic abnormalities [3–6]. Total dietary energy intake and macronutrient composition are
well-known to modulate glycemia [4,7]. Restricting energy intake and the resultant reductions in
body weight improves these modifiable risk factors for T2D [8–10]. Nevertheless, maintaining energy
restriction and weight loss over the long-term is challenging [11]. Manipulating dietary macronutrient
composition without restricting energy has also been shown to be an effective dietary strategy for
prevention of T2D [12,13].
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The quantity and quality of carbohydrate and protein in a mixed meal modulate postprandial
glucose and insulin concentrations, with the total amount and the type of carbohydrate consumed
being the major contributors to postprandial glucose concentration [14–16]. An increased
amount of digestible/metabolizable carbohydrate consumed is associated with higher postprandial
glycemia [17–19], which increases the risk of developing T2D [20,21]. On the other hand, a higher
amount of complex/indigestible carbohydrates, such as soluble, viscous, and gel-forming fibers [22–24]
may attenuate postprandial glucose concentrations [25–29]. Among different forms of soluble
fibers, psyllium fiber is known to consistently attenuate fasting and postprandial glucose and
insulin [30,31] and distinctly exert a laxation effect when consumed with meals [32]. Dietary protein
appears to stimulate insulin secretion in people with normal glucose tolerance and T2D [33–35] and
this insulinotropic effect of protein is related to secretagogue amino acids, such as arginine and
leucine [33]. Eggs are a complete protein source with a relatively high leucine content [36]. Evidence
supporting a glucose lowering effect of eggs is inconclusive [37–39]. Experimental evidence supports
metabolic effects of protein and fiber in blunting postprandial and long-term glucose responses
independently [7,12,13,35,40]. However, the extent to which the effects of protein and fiber intakes on
postprandial glucose when co-consumed may be additive are uncertain, particularly in overweight
individuals, who may be at risk of developing T2D.
While traditional meal tolerance tests adequately assess the impact of meals/diets on postprandial
glucose and insulin responses, this method does not support the assessment of daylong glucose control.
Continuous glucose monitoring (CGM) is an emerging technique that is used to determine the 24-h
pattern of interstitial glucose concentrations in community-dwelling individuals [41,42]. The CGM
technique may be preferred to inpatient meal tolerance tests to track the impact of dietary intake on
daylong glucose responses, particularly when the impact of self-selected dietary intake on glycemia
is of interest. By using this approach, the suggested extended favorable effects of protein and fiber
intakes on daylong glucose control can be assessed.
We conducted a randomized controlled crossover trial to assess the independent and combined
effects of normal versus higher egg-based protein and fiber intakes at breakfast on postprandial
glycemic and insulinemic responses as well as 24-h glucose patterns with CGM. The study focused
on breakfast because the typical intakes of protein and fiber at this meal are lower than at lunch
and dinner [43]. In addition, some previous studies suggest that higher protein [13,44,45] or
fiber [46,47] intake at breakfast, particularly protein, may have favorable metabolic benefits by
enhancing insulin-mediated glucose disposal due to increased insulin secretion. We hypothesized
that co-consumption of higher quantities of egg-based protein and fiber at breakfast would lower
postprandial glucose and 24-h glucose responses.
2. Materials and Methods
2.1. Participants
Overweight male and female adults were recruited from the Greater Lafayette, Indiana, USA, area
through advertisement to participate in the study. The inclusion criteria for selection of participants
were: age 21–45 years; body mass index (BMI) 25–29.9 kg/m2; females with regular menstrual cycles;
non-smoking; not taking medications or dietary/herbal supplements known to affect energy regulation
or appetite; not pregnant or lactating within the past 1 year or planning a pregnancy; weight stable
(±3 kg) for the past 3 months; not following a vigorous exercise regimen or weight loss program
within the past 6 months; no acute illness; not diabetic (fasting blood glucose≤126 mg/dL (7 mmol/L);
not severely claustrophobic; willing to eat study foods; and not skipping breakfast >2 day/week.
Eligible individuals were approved by the study physician to participate based on routine blood
chemistry assessments. All participants gave written informed consent and the study had approval
from the Purdue University Biomedical Institutional Review Board. Figure 1 shows participants’
flow through the study. Baseline participant characteristics were not statistically different (p > 0.05)
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between groups of participants who did versus did not complete the study. Two male participants
were withdrawn from the study after randomization by the investigators due to an inability to fully
comply with study procedures. These participants did not find the CGM comfortable to wear (one after
three days of wearing the device and the other at the end of first intervention period). Four participants
had scheduling conflicts. One of these individuals was not able to show up for the first test day
appointment. The other three withdrew from the study after completing one or two testing periods.
Data for these three participants were not included in the analysis. We obtained and included data
from the 20 study completers in the postprandial glucose and insulin analysis. However, one of
these 20 participants was unable to wear the CGM because it interfered with his farming occupation.
This trial was registered on ClinicalTrials.gov (NCT02169245).
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were  scheduled  to  occur  on  the  last  day  of  each  2‐week  intervention  period.  Twenty‐four‐hour 
interstitial  glucose  patterns  were  assessed  by  CGM  during  the  second  week  of  each  2‐week 
intervention period. On the last day of each intervention period, a meal tolerance test was performed. 
Participants arrived at our clinical research facility after a 10‐h overnight fast. Upon arrival, a fasting 
blood  draw was  obtained.  Participants  next  consumed  the  same  breakfast  type  (NPNF, NPHF, 
HPNF,  and HPHF)  that  they  had  eaten  for  the  preceding  2‐week  dietary  intervention  period. 
Participants were asked to consume the entire breakfast in no more than 15 min. Postprandial blood 
draws were obtained hourly for 4 h after the completion of breakfast. Fasting and postprandial serum 
samples  were  analyzed  for  glucose  and  insulin  concentrations.  Each  2‐week  period  of  dietary 
intervention was separated by ≥15 days (mean: 17 days, range: 15–36 days) during which time the 
participants were asked to consume their habitual diets. Study investigators (with the exception of 
Figure 1. Consort diagram of the study.
2.2. Experiment l Design
Participants completed this randomized crossover trial in approximately 15 weeks. Participants
consumed four breakfast meals that vari d in protein and fib r mounts daily for 2 w eks in random
order. The breakfast types were normal protein and fiber (NPNF), normal protein and high fiber
(NPHF), high protein and normal fiber (HPNF), and high protein and fiber (HPHF). During each
2-week intervention period, participants consumed the designated breakfast type every morning,
but foods and beverages outside of breakfast wer otherwise uncontrolled and elf-chosen. Testing
days were scheduled to occur on the last day of each 2-week intervention period. Twenty-four-hour
interstitial glucose patterns were assessed by CGM during the second week of each 2-week intervention
period. On the last day of each intervention period, a meal tolerance test was performed. Participants
arrived at our clinical res arch facility fter a 10-h overnight fa Upon arrival, fasting blood draw
was obtained. Participants next consumed the same breakfast type (NPNF, NPHF, HPNF, and HPHF)
that they had eaten for the preceding 2-week dietary intervention period. Participants were asked to
consume the entire breakfast in no more than 15 min. Postprandial blood draws were obtained hourly
for 4 h after the completion of breakfast. Fasting and postprandial serum samples were analyzed
for glucose and insulin concentrations. Each 2-week period of dietary intervention was separated
by ≥15 days (mean: 17 days, range: 15–36 days) during which time the participants were asked to
consume their habitual diets. Study investigators (with the exception of the research dietitian, AJW)
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and participants were blinded to the protein and fiber content of the breakfast treatments during the
study data collection period.
2.3. Breakfast Characteristics
All breakfast recipes (Tables S1–S16 were designed by a research dietitian (AJW) using ProNutra
(Release 3.2, Viocare Technologies, Inc., Princeton, NJ, USA) and were prepared by metabolic
research kitchen staff in conjunction with the NIH-supported bionutrition center at Purdue University.
Breakfasts were provided to the participants to consume either on-site or at a self-chosen location.
Four varieties (egg and potato casserole, quiche, breakfast sandwich, and breakfast burrito) of each
breakfast type were provided within each 2-week intervention period to provide variety. Within
each breakfast variety, pilot testing was completed to ensure comparable palatability and textural
characteristics across NPNF, NPHF, HPNF, and HPHF breakfasts. While all breakfast varieties were
designed to achieve the similar energy, macronutrient, and fiber amounts, the breakfast burrito was
consumed on all testing days to provide additional consistency (Table 1).
Table 1. Energy and macronutrient distribution of provided breakfast treatments.
Dietary Variables
Breakfast Treatments
NPNF HPNF NPHF HPHF
* Energy (kcal) 396 397 387 386
Available Carbohydrate (g) 51 50 51 48
Sugar (g) 18 22 11 14
Total Fiber (g) 2 2 8 8
Soluble Fiber (g) 0 1 6 7
Insoluble Fiber (g) 2 1 2 1
Total Protein (g) 12.5 25 12.5 25
Total Fat (g) 16 10 14 10
Saturated Fat (g) 4 3 4 3
Monounsaturated Fat (g) 6 3 6 3
Polyunsaturated Fat (g) 3 1 2 1
Trans Fat (g) 0 0 0 0
Cholesterol (mg) 114 325 114 325
Sodium (mg) 767 723 765 720
* Metabolizable energy. Data are based on information from ProNutra, Release 3.2, Viocare Technologies, Inc.,
Princeton, NJ, USA. NPNF: Normal Protein + Normal Fiber; HPNF: High Protein + Normal Fiber; NPHF: Normal
Protein + High Fiber; HPHF: High Protein + High Fiber.
All four breakfast types (NPNF, NPHF, HPNF, and HPHF) provided ~400 kcals of metabolizable
energy and contained ~50 g of available carbohydrate. High and normal protein were defined as 25 g
and 12.5 g of protein, respectively. The increases in breakfast protein content for HPNF and HPHF
were achieved by the addition of whole eggs and/or egg products such as egg white powder; and
fat content was reduced to maintain similar total energy content among breakfast types. The high
and normal fiber intakes were defined as 8 g, and 2 g, respectively. The additional fiber in NPHF and
HPHF was achieved by adding powdered psyllium husk to the meals, which was shown to reduce
postprandial glucose responses [30,31] and can easily be incorporated into meals for participant and
investigator blinding. The energy, protein, and fiber content of the NPNF breakfasts were designed to
resemble reported breakfast characteristics for adult males and females as described in the 2013–2014
What We Eat in America data tables [43]. The protein contents of HPNF and HPHF were doubled to
25 g (25% of energy at breakfast), which is consistent with published definitions of HP diets [48,49].
2.4. Dietary Intake
Self-selected food and beverage intakes during each intervention period were determined using
the multiple-pass approach on three unscheduled days (one weekend day and two non-consecutive
weekdays) and analyzed by the research dietitian using Nutrition Data System for Research
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(NDSR) software, version 2013 (Nutrition Coordinating Center, Univ. MN, Minneapolis, MN, USA).
Two-dimensional food portion visuals (Nutrition Coordinating Center, Univ. MN, Minneapolis, MN,
USA) were used to assist subjects in estimating portion sizes.
2.5. Body Composition
Standing height without shoes was measured during baseline with a wall-mounted stadiometer.
Whole body mass, fat mass, and lean mass were also determined at baseline using air displacement
plethysmography (BOD POD, COSMED USA, Concord, CA, USA). Body mass index was calculated
as body mass divided by height squared (kg/m2).
2.6. 24-h Glucose (CGM)
A Medtronic iPro2 Professional CGM device (Northridge, CA, USA) was used to obtain 24-h
continuous interstitial glucose concentration data from study participants during the last 7 days of each
dietary intervention period. The glucose oxidase-based sensor inserted into the abdominal area at least
5 cm away from the umbilicus obtain an interstitial glucose measurement every 10 s and a recorder
stored a smoothed and filtered average of these values every 5 min. Data obtained on the first and last
day while participants wore the CGM device were excluded to obtain 24-h glucose data within periods
where CGM sensor functional life was ideal. We considered 24-h glucose data valid when three or more
self-monitoring glucose reading (finger sticks) were documented for calibration of CGM sensor glucose
data [50]. CGM data were used to calculate 24-h interstitial glucose peak, mean, coefficient of variation
(CV) and total area under the curve (AUC). The group mean and peak glucose were calculated from the
individual participants’ means of 2–5 days of useable CGM data. Similarly, group CV was calculated
as mean of the ratio of the individual participants’ standard deviation to mean. Also, in a subset of
participants, the CGM data were used to document the postprandial glucose responses for 75 min after
participants consumed the same trial-specific breakfast test treatment (breakfast burrito) as consumed
during the corresponding meal tolerance test and also consumed their next meal or beverage by 75 min
after consuming the test-specific breakfast treatment. Only participants who provided these data
(obtained on different days) were used to graphically show the postprandial glucose responses in
more detail (interstitial fluid samples every 5 min) to complement blood sampling (serum samples
every hour) during the meal tolerance tests.
2.7. Biochemical Analyses and Calculation
Each blood sample was collected into vials containing serum separator and silica clot activator
that were inverted several times and maintained at room temperature for 45 min to allow clotting
and then centrifuged at 4 ◦C for 10 min at 4400 rpm. The resulting serum aliquots were stored
at −80 ◦C until thawed for measurements of glucose by enzymatic colorimetry using an oxidase
method on a COBAS Integra 400 analyzer (Roche Diagnostic Systems USA, Indianapolis, Indiana) and
insulin by an electrochemiluminescence immunoassay method on the Elecsys 2010 analyzer (Roche
Diagnostic USA, Indianapolis, Indiana). The trapezoidal method [51] was used to calculate total AUC
for glucose and insulin at 0–120 min, 120–240 min, and 0–240 min time periods. The homeostatic
model assessment (HOMA) insulin resistance (HOMA-IR), HOMA β-cell function (HOMA-%β) and
whole-body (composite) insulin sensitivity index (ISI) were calculated as previously described [52,53].
2.8. Statistical Analysis
Independent t-test was used to assess baseline metabolic health indices between the individuals
who completed vs. those who did not complete the study. Doubly repeated-measures ANOVA (PROC
MIXED) was used to assess the effects of protein intake (normal vs. high), fiber intake (normal vs. high),
and time (fasting-state (0) vs. 60 vs. 120 vs. 180 vs. 240 min), protein × time, fiber × time, and protein
× fiber × time interactions on serum fasting and postprandial glucose and insulin. The 2 repeated
factors in our model were time and intervention period. Repeated-measures ANOVA (PROC MIXED)
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was used to assess the effects of breakfast meal treatments on 0–120, 120–240, and 0–240 min AUCs;
24-h interstitial glucose peak, mean, and CV, and predictive indices of glucose control measures
HOMA-IR, HOMA-%β, and ISI. Data are presented as unadjusted mean ± standard deviation (SD)
for participant characteristics and mean ± standard error of the mean (SEM) for all other results.
We adjusted for fasting-dependent variable values (only when the outcome variable was expressed as
AUC), sex, breakfast treatment order (chronological testing order: Period 1 vs. Period 2 vs. Period 3
vs. Period 4), and intervention carryover effect, as previously described [54]. Post hoc analyses were
performed using Tukey–Kramer adjustment for multiple comparisons. Statistical significance was set
using α = 0.05, two-tailed. Statistical Analysis Systems software, version 9.3 (SAS Institute Inc., Cary,
NC, USA) was used to perform all statistical analyses.
3. Results
3.1. Participant Characteristics
Participants were apparently healthy young overweight adults (seven females, 13 males). Baseline
fasting glucose, lipid and lipoprotein concentrations were within the clinically normal reference
ranges (Table 2).
Table 2. Baseline participant characteristics.
Variable Mean± SD
Age (years) 26 ± 5
Height (cm) 175 ± 10
Body Mass (kg) 83.4 ± 10.2
BMI (kg/m2) 27.0 ± 1.3
% Body Fat 26.4 ± 9.5
Serum glucose (mmol/L) 5.2 ± 0.3
Total cholesterol (mmol/L) 4.3 ± 0.5
Low-density lipoprotein cholesterol (mmol/L) 2.6 ± 0.5
High-density lipoprotein cholesterol (mmol/L) 1.2 ± 0.2
Triglycerides (mmol/L) 1.1 ± 0.4
Values are means ± standard deviation (SD) for n = 20 participants. BMI: body mass index.
3.2. Breakfast Treatments Effect on Outcome Measures
3.2.1. The Effect of Breakfast Treatment on Fasting Glucose and Insulin Variables
Fasting serum glucose, insulin, and predictive indices of glucose control including HOMA-IR, ISI,
and HOMA-β (%) measured on the last day of each two-week breakfast treatment were not different
among treatments (Table 3).
Table 3. Fasting serum glucose, insulin, and indices of glucose control after two weeks of breakfast
meals consumption.
Fasting Variables
Breakfast Treatments
NPNF HPNF NPHF HPHF p
Glucose (mmol/L) 5.3 ± 0.2 5.3 ± 0.2 5.2 ±0.1 5.2 ± 0.2 0.924
Insulin (pmol/L) 36 ± 6 36 ± 6 42 ± 6 42 ± 6 0.695
HOMA-IR 1.39 ± 0.1 1.51 ± 0.2 1.55 ± 0.2 1.54 ± 0.2 0.713
ISI 33 ± 5.2 32 ± 4.7 30 ± 5.6 31 ± 4.3 0.803
HOMA-β (%) 79 ± 10.2 79 ± 9.5 115 ± 36.9 88 ± 18.2 0.740
n = 20. Estimates are mean ± SEM. Homeostatic model assessment (HOMA) insulin resistance (HOMA-IR), HOMA
β-cell function (HOMA-%β); whole-body (composite) insulin sensitivity index (ISI). The main effects of protein
(high vs. low) and fiber (high vs. low) and their interaction on these fasting variables were assessed using a
repeated-measures PROC mixed effects model, adjusting for sex, dietary treatment order, and carryover effect.
NPNF: Normal Protein + Normal Fiber; HPNF: High Protein + Normal Fiber; NPHF: Normal Protein + High Fiber;
HPHF: High Protein + High Fiber.
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3.2.2. Time Course of Postprandial Glucose and Insulin Responses (AUC)
Results from meal tolerance testing showed that over time, postprandial glucose (p = 0.005)
and insulin (p < 0.0001) responses occurred. Compared to fasting (time 0), insulin was higher at 60
and 120 min and glucose was lower at 60 min. The protein and/or fiber contents of the breakfast
treatments did not affect 240-min glucose AUC. Protein intake did not affect 240-min insulin AUC,
while higher fiber intake lowered 240-min insulin AUC (p = 0.030). Further analysis of the insulin
AUCs indicated that higher fiber intake reduced insulin AUC at 120–240 min (p = 0.002), but not at
0–120 min (p = 0.245) (Figures 2 and 3). The apparent lack of a postprandial rise in glucose prompted
an assessment of CGM-based interstitial glucose data from days that participants consumed the same
treatment-specific breakfast burritos. Indeed, interstitial glucose increased after consumption of each
breakfast meal treatment, peaking after about 30 min, and decreasing to baseline concentrations by
60–75 min (Figure 4). An effect was observed for fiber (p = 0.017) but not protein (p = 0.631) or their
interaction (p = 0.795).
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Figure 2. Postprandial time course (A) and total area under the curve (AUC) (B) for insulin response
to breakfast treatments. Postprandial time points with different letters are statistically different
(main effect of time, p < 0.05). n = 20, Estimates are unadjusted mean± SEM. The main effects of protein
(high vs. low) and fiber (high vs. low) and their interaction on postprandial insulin were assessed
using a repeated-measures PROC mixed effects model, adjusting with fasting glucose (AUC only),
for sex, dietary treatment order, and carryover effect. An effect was observed for fiber at 120–240 min
(p = 0.002) and 0–240 min (p = 0.030) but not protein at 120–240 min (p = 0.113) or 0–240 min (p = 0.569)
or their interaction (p = 0.944). NPNF: Normal Protein + Normal Fiber; HPNF: High Protein + Normal
Fiber; NPHF: Normal Protein + High Fiber; HPHF: High Protein + High Fiber.
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Figure 4. Postprandial time course (A) and total area under the curve (AUC) (B) for continuous glucose
monitoring (CGM)-measured interstitial glucose after treatment-specific breakfast test meals (breakfast
burrito) were consumed. Estimates are unadjusted mean ± SEM. The main effects of protein (high vs.
low) and fiber (high vs. low) and their interaction on postprandial interstitial glucose were assessed
using a repeated-measures PROC mixed effects model, adjusting with fasting glucose (AUC only),
for sex, dietary treatment order, and carryover effect. An effect was observed for fiber (p = 0.017) but
not protein (p = 0.631) or their interaction (p = 0.795). NPNF: Normal Protein + Normal Fiber; HPNF:
High Protein + Normal Fiber; NPHF: Normal Protein + High Fiber; HPHF: High Protein + High Fiber.
NPNF: n = 11, HPNF: n = 15, NPHF: n = 14, HPHF: n = 14.
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3.3. 24-h Interstitial Glucose Variables
Among the four breakfast treatments, we did not observe differential responses in the interstitial
glucose 24-h peak (p = 0.768), mean (p = 0.255), and CV (p = 0.534) and AUC (p = 0.179)
(Table 4). Comparable 24-h interstitial glucose profiles were observed for all breakfast treatments
(Supplementary Figure S1).
Table 4. Breakfast treatment effects on 24-h interstitial glucose variables.
Glucose Variables
Breakfast Treatments
NPNF HPNF NPHF HPHF p
Peak (mmol/L) 7.4 ± 0.2 7.1 ± 0.2 7.2 ± 0.1 7.2 ± 0.2 0.768
Mean (mmol/L) 5.5 ± 0.1 5.5 ± 0.1 5.5 ± 0.1 5.2 ± 0.1 0.255
Variability (CV) 0.99 ± 0.54 0.33 ± 0.23 0.30 ± 0.24 0.60 ± 0.38 0.534
AUC (mmol/L × 1440 min) 7982 ± 109 7977 ± 123 7755 ± 109 7860 ± 104 0.179
n = 19. Estimates are mean ± SEM. CV, coefficient of variation. AUC: total area under the curve. The main effects
of protein (high vs. low) and fiber (high vs. low) and their interaction on 24-h interstitial glucose variables were
assessed using a repeated-measures PROC mixed effects model, adjusting for sex, dietary treatment order, and
carryover effect. No effect was observed for fiber and protein or their interaction. NPNF: Normal Protein + Normal
Fiber; HPNF: High Protein + Normal Fiber; NPHF: Normal Protein + High Fiber; HPHF: High Protein + High Fiber.
3.4. Daily Energy and Macronutrients Intake
Among the four breakfast treatments, we did not observe differential responses in either the
non-breakfast energy intake (self-chosen energy intake) (p = 0.421) or daily energy intakes (breakfast
energy + self-chosen energy intakes after breakfast meals) (p = 0.394) (Supplementary Table S17 and S18),
respectively. While we did not observe differences with the non-breakfast macronutrients intakes
(Supplementary Table S17), we did observe differences in the daily total dietary fiber (p = 0.021),
soluble fiber (p < 0.0001), and polyunsaturated fatty acids (p = 0.015) intakes but not the other
macronutrients assessed (Supplementary Table S18).
4. Discussion
We conducted this study with the primary aim to assess the combined effect of higher intakes
of protein and fiber consumed daily at breakfast over a 2-week period on postprandial glucose and
insulin responses. We hypothesized that increasing protein and fiber amounts at breakfast would blunt
postprandial serum glucose responses compared to increasing either protein or fiber alone. Contrary to
our hypotheses, we observed that increasing protein and fiber amounts at breakfast did not influence
postprandial glucose responses in overweight young adults. However, we observed an effect of fiber
on insulin response (AUC). Increasing fiber lowered both the last two hours (120–240 min) and the
composite 240-min insulin AUCs. Also, we did not observe protein and/or fiber breakfast meal effects
on 24-h interstitial glucose or indices of glucose control.
Results from the meal tolerance tests suggested the lack of a postprandial glucose response that
may be explained by the timing of blood sampling in the current study. Specifically, it is likely that
postprandial glucose concentrations peaked and began returning to baseline levels before the first
postprandial sample 60 min after breakfast. This is supported by interstitial glucose data obtained via
CGM that showed peak glucose concentrations approximately 30 min after breakfast and declining
to baseline concentration by 60–75 min. Generally, the expected postprandial glucose peak occurs
one hour postprandial in overweight and obese adults [46]. This supported our choice of hourly
blood sampling for the meal tolerance testing because our study participants were overweight adults.
Other studies that included varying amounts of fiber [55] and protein [44,56] to meals also reported
shorter postprandial glucose peaks occurring within 30–45 min but declining to either baseline or
below baseline glucose concentration by 60 min. However, a modestly elevated postprandial insulin
at 60 min was concurrently reported by those studies with meal tolerance testing. Our results are
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consistent with such studies. We observed that glucose concentration 60 min after breakfast was
slightly, but statistically, lower than the fasting serum glucose concentration. Our results, together with
others, suggest that future studies must always use frequent blood sampling (15-min interval within
the first hour of feeding), particularly when both fiber and protein amounts are varied in test meals, to
possibly avoid missing important data points within the first hour after feeding.
Studies assessing whether the consumption of higher amounts of protein and fiber simultaneously
would better attenuate postprandial glucose response compared to when either protein or fiber is
increased and consumed separately are lacking. To our knowledge, only one study assessed the
effects of a moderate protein (from egg source) and high fiber (whole grains) breakfast treatment
(protein = 20 g, fiber = 7 g, carbohydrates = 45 g) compared with a refined rice cereal breakfast
(protein = 10 g, fiber = 1 g, carbohydrate = 55 g) [57]. Bonnema et al. [57] reported an attenuation
of 3.5-h AUC glucose with the moderate protein and high fiber breakfast. Results of insulin AUC
were not reported. Of note, the difference in carbohydrate content of those breakfasts may explain
the glucose results as opposed to the combined effect of protein and fiber. In contrast, one previous
study [58] systematically assessed the individual and combined effects of low vs. high glycemic index
(GI) and protein breakfast treatments on postprandial insulin and glucose responses. Makris et al. [58]
found that combining higher amounts of protein and low GI simultaneously did not have an effect
on postprandial insulin and glucose responses. However, intake of higher amounts of the low GI
breakfast meal attenuated postprandial insulin and glucose responses. We also did not observe an
additive effect with intake of higher amounts of protein and fiber on postprandial insulin and glucose.
Collectively, the expected favorable additive effect with increasing the amount of protein and either
low GI carbohydrates or fiber from whole grains sources and fiber per se on postprandial insulin and
glucose responses is inconclusive.
Our results partially supported the favorable metabolic effects established for soluble viscous
fibers. The 6-g difference between the normal fiber (2 g) and high fiber (8 g) breakfast treatments
was achieved by adding psyllium husk powder, which is known as a soluble fiber. We observed that
increasing soluble fiber intake attenuated the postprandial insulin response. Other studies noted that
increasing soluble fiber when a meal had greater amounts of high glycemic index foods/metabolizable
carbohydrate content attenuated postprandial glucose [55,59] and insulin [55] responses. The lowering
of insulin with increasing dietary fiber intake that was observed in our study is consistent with
previous findings [27,55,60]. Reducing postprandial insulin with higher fiber intakes has beneficial
metabolic effects in healthy overweight individuals who are at risk of developing hyperinsulinemia,
an early abnormality preceding the development of type 2 diabetes. Insulin resistance with concurrent
compensatory hyperinsulinemia is a major feature that underlies the development of metabolic
morbidities, particularly, type 2 diabetes [61]. This compensatory elevation of insulin secretion
is usually needed to achieve a normal postprandial glucose response in overweight and obese
individuals [62] after a meal. Intervention strategies that alleviate the need for elevated insulin secretion
for glucose clearance are beneficial. While dietary interventions that vary dietary macronutrient
composition without inducing weight lost do not consistently improve insulin resistance, manipulating
the dietary macronutrient content has been documented to impact the insulin resistance-induced
hyperinsulinemia [46]. Therefore, increasing dietary fiber supported improvement in insulin sensitivity
(lower insulin concentration to normalize blood glucose) as previously established [24,47].
In addition to assessing postprandial glucose and insulin responses by meal tolerance testing,
our study design allowed us to evaluate potential “second meal effects” with CGM. Jenkins et al. [63]
defined second meal effects as an effect of a first meal on the postprandial glucose response after eating
the second meal. Consuming higher amounts of fiber and protein were previously shown to elicit
“second meal effects” by reducing postprandial glucose responses following a second meal [64–67].
Other studies also reported an attenuation of daylong glucose (lunch and dinner meals) with intake of
low GI foods [68]. Assessing such a prolonged effect of consuming a breakfast with controlled protein
and fiber amounts on subsequent and uncontrolled meals was an important and novel aim of the
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current study. However, 24-h interstitial glucose variables, including AUC, were not influenced by
the 4 breakfast treatments used in the current study, which suggests a lack of a “second meal effect”.
Our results may be due to the observed large variability between participants’ self-selected intake after
the breakfast meal (Tables S17 and S18). Our findings could also suggest that the inclusion of fiber
in multiple meals across the day may be needed with the intake of a typical Western diet to improve
daily glycemic control.
One limitation of the study was that the lack of provision of a standard meal the night before the
acute measurement to metabolically stabilize our study participants may have confounded our study
outcomes. Previous studies suggest a residual effect from dinner meals may impact the next morning
glucose profile [68] particularly with high fiber intake. Another limitation was the fact that we could
not match sugar, MUFA, PUFA, and total fat, across normal vs. the high breakfast treatment meals
although these nutrients may influence our results. However, the magnitude of the differences in the
amounts of the afore-mentioned nutrients between the normal vs. high protein and fiber breakfast
treatments where not numerically substantial. Lastly, our study findings are only generalizable to
overweight young adults. A strength of this study is that both researchers and study participants
were blinded to the study dietary treatment. This potentially eliminates any biases with our dietary
manipulation that may influence our study outcomes. Another strength is that the 2-week dietary
acclimation period before our postprandial responses were assessed allowed us to determine the
prolonged effects of consumption of protein and fiber breakfasts beyond a single meal.
5. Conclusions
In conclusion, consumption of a breakfast meal with both higher protein and fiber content did
not differentially influence postprandial glucose response and 24-h glucose peak and AUC compared
to the other three breakfast treatments. However, increasing fiber had an attenuation effect on the
postprandial insulin response. Therefore, doubling the amount of protein from 12.5 g to 25 g/meal and
quadrupling fiber from 2 to 8 g/meal simultaneously at breakfast may not be an effective therapeutic
strategy to improve insulin and glucose responses acutely; however, higher fiber intake at breakfast
may be effective for lowering the postprandial insulin response in healthy overweight, young adults.
Supplementary Materials: The following are available online at www.mdpi.com/2072-6643/9/4/352/s1,
Figure S1: 24-hour time course interstitial glucose from CGM to breakfast treatments and self-selected intakes after
provided breakfast. n = 19, Estimates are unadjusted means. NPNF: Normal Protein + Normal Fiber; HPNF: High
Protein + Normal Fiber; NPHF: Normal Protein + High Fiber; HPHF: High Protein + High Fiber, Table S1: NPNF
breakfast burrito recipe, Table S2: HPNF breakfast burrito recipe, Table S3: NPHF breakfast burrito recipe, Table S4:
HPHF breakfast burrito recipe, Table S5: NPNF breakfast sandwich recipe, Table S6: NPHP breakfast sandwich
recipe, Table S7: NPHF breakfast sandwich recipe, Table S8: HPHF breakfast sandwich recipe, Table S9: NPNF
breakfast casserole recipe, Table S10: HPNF breakfast casserole recipe, Table S11: NPHF breakfast casserole recipe,
Table S12: HPHF breakfast casserole recipe, Table S13: NPNF breakfast quiche recipe, Table S14: HPNF breakfast
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